UNSPSC 51112509: Chlormethine or mechlorethamine

This classification denotes a nitrogen mustard compound with the molecular formula C5H11Cl2N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50D9XSG0VR, chemically known as 2,2-dichloro-n-methyldiethylamine but more generally known as chlormethine, which bears US NIH Compound Identifier 4033. European Medicines Agency schedules Chlormethine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06186MIG.

UNSPSC 51112509 Chlormethine or mechlorethamine is a Commodity code that designates a nitrogen mustard chemotherapy agent used in cancer treatment regimens. State and local governments procure this drug primarily through health and human services departments, correctional healthcare systems, and state employee health plans that provide oncology coverage. The Texas Health and Human Services Commission has recently issued a Request for Information exploring direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager and group purchasing organization channels, signaling state interest in alternative supply and contracting arrangements for specialty pharmaceuticals. Issuing bodies under this code span state health agencies and related programs that manage pharmacy benefits for Medicaid, state employees, and corrections populations.

The recent RFI from Texas HHS (HHS0017013, response due April 3, 2026) represents exploratory procurement activity aimed at establishing direct vendor relationships with pharmaceutical manufacturers to improve prescription fulfillment efficiency and cost management for specialty drugs. The state is gathering vendor information on direct contracting capabilities, negotiated net pricing models, and outcomes-based agreement structures before issuing a formal RFP. This preliminary information-gathering phase does not commit specific funding amounts or timelines but signals Texas intent to reshape its specialty pharmaceutical supply chain beyond incumbent PBM and wholesaler arrangements. Geographic activity under the code concentrates in Texas based on current visibility; the broader universe of state and local procurement under this Commodity code remains limited, as specialty chemotherapy agents are typically procured through established health plan channels and manufacturer direct-supply relationships rather than open competitive solicitations.